Search
for

    Sort by

    Research 721–750 of 1000+

    1. The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being Current Sexual Health Reports · 2015 · 1 citations
    2. Finasteride Induced Cerebral Venous Thrombosis Journal of the Korean neurological association · 2015 · 1 citations
    3. Pregnancy Outcomes with Paternal Exposure to Finasteride, a Synthetic 5-Alpha-Reductase Inhibitor: A Case Series Journal of Clinical Toxicology · 2015 · 1 citations
    4. 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향 Journal of the Korean Society of Food Science and Nutrition · 2014 · 1 citations
    5. Finasteride and male infertility: a case for prospective collaborative research databases? Fertility and Sterility · 2013 · 1 citations
    6. Clinical research on preoperative application of finasteride in reducing transurethral resection syndrome Shandong yiyao · 2013 · 1 citations
    7. Finasterid in der Behandlung der benignen Prostatahyperplasie Der Urologe · 2012 · 1 citations
    8. Finasteride and male fertility Journal of Human Reproductive Sciences · 2011 · 1 citations
    9. Comparative Effect of Finasteride and Dutasteride on Chromogranin A Levels Anticancer Research · 2010 · 1 citations
    10. EFFECTS OF FESOTERODINE, A NOVEL ANTIMUSCARINIC, ALONE AND IN COMBINATION WITH AN α-RECEPTOR BLOCKER, DOXAZOSIN, ON BLADDER FUNCTION IN OBSTRUCTED RATS The Journal of Urology · 2009 · 1 citations
    11. Crystal Structure and Synthesis of 17.ALPHA.-Acetoxy-6,7-epoxypregn-4-ene-3,20-dione X-ray Structure Analysis Online · 2009 · 1 citations
    12. Editorial Comment Urology · 2008 · 1 citations
    13. Many sexual adverse effects of finasteride are attributable to a nocebo effect Nature Clinical Practice Urology · 2008 · 1 citations
    14. PD-02.09 Urology · 2006 · 1 citations
    15. Editorial comment The Journal of Urology · 2005 · 1 citations
    16. Terapia antiandrogénica como quimioprevención del cáncer de próstata Medicina de Familia SEMERGEN · 2004 · 1 citations
    17. High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma Journal of Chromatography B: Biomedical Sciences and Applications · 1997 · 1 citations
    18. Office Dermatology Postgraduate medicine · 1965 · 1 citations
    19. Erythema Centrifugum: The Unexpected Hidden Cause Zenodo (CERN European Organization for Nuclear Research) · 2026
    20. Erythema Centrifugum: The Unexpected Hidden Cause Zenodo (CERN European Organization for Nuclear Research) · 2026
    21. Study on the mechanism that SNPs related to sex hormone metabolism regulate the imbalance of sex hormones and lead to BPHin rats Figshare · 2026
    22. Study on the mechanism that SNPs related to sex hormone metabolism regulate the imbalance of sex hormones and lead to BPHin rats Figshare · 2026
    23. 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database Journal of the American Academy of Dermatology · 2026
    24. The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis World Journal of Urology · 2026
    25. Isolation and Structural Characterization of Finasteride Degradation Products by Preparative HPLC, HRMS, and NMR International Journal of Scientific Research in Chemistry · 2026
    26. Finasteride. dutasteride risk of suicide and sexual dysfunction Reactions Weekly · 2026
    27. Persistent Sexual and Psychological Symptoms After Finasteride Discontinuation: A Cross-Sectional Observational Study Journal of Clinical Medicine · 2026
    28. METHOD DEVELOPMENT AND VALIDATION OF UV-SPECTROPHOTOMETRIC ESTIMATION OF FINASTERIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM International Journal of Pharmaceutics and Drug Analysis · 2026
    29. FINASTERIDE IN MODERN MEDICINE: THERAPEUTIC APPLICATIONS AND SYSTEMIC HEALTH IMPLICATIONS RS Global journals (RS Global Sp. z O.O.) · 2026
    30. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) Figshare · 2026